Huda Al-Baldawi

  • Principal engineer; MSc
  • +47 230 13 916
 

Publications 2025

Granerud BK, Kaarbø M, Al-Baldawi H, The Norwegian Sars-CoV-Study Group Investigators, Otterdal K, Halvorsen B, Lind A, Rayner S, Holter JC, Dudman S (2025)
Droplet Digital PCR or Real-Time PCR as a Method for Quantifying SARS-CoV-2 RNA in Plasma-Is There a Difference?
Viruses, 17 (6)
DOI 10.3390/v17060772, PubMed 40573363

Queirós-Reis L, Kaarbo̷ M, Al-Baldawi H, Alvites R, Maurício AC, Brancale A, Bassetto M, Mesquita JR (2025)
In Silico Discovery of a Novel Antiviral Scaffold for SARS-CoV‑2 Targeting the Spike Glycoprotein through the Fatty Acid Binding Pocket
ACS Omega, 10 (23), 24117-24132
DOI 10.1021/acsomega.4c10519, PubMed 40547706

Publications 2022

Granerud BK, Ueland T, Lind A, Søraas A, Fevang B, Steffensen AK, Al-Baldawi H, Lund-Johansen F, Aukrust P, Halvorsen B, Dahl TB, Dudman S, Müller F, Holter JC (2022)
Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2
Viruses, 14 (11)
DOI 10.3390/v14112420, PubMed 36366518

Søraas A, Grødeland G, Granerud BK, Ueland T, Lind A, Fevang B, Murphy SL, Huse C, Nygaard AB, Steffensen AK, Al-Baldawi H, Holberg-Petersen M, Andresen LL, Ågnes C, Ranheim T, Schanke Y, Istre M, Dahl JA, Chopra A, Dudman S, Kaarbø M, Andersen JT, Vaage EB, Tran TT, Vaage JT et al. (2022)
Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
Front Immunol, 13, 964525
DOI 10.3389/fimmu.2022.964525, PubMed 36159859